Search

everythinglearnresearchcommunity

for

Search:↓

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Glibenclamide slows breast cancer cell growth by stopping cell division.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.